Cargando…
Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction
The recent COronaVIrus Disease (COVID)-19 pandemic has placed an unprecedented burden on the drug development opportunity to prevent the onset of multi-organ failure. Emerging experimental reports have highlighted the beneficial effects of mesenchymal stem cell (MSC) administration against COVID-19....
Autores principales: | Safari, Anahid, Lionetti, Vicenzo, Razeghian-Jahromi, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280613/ https://www.ncbi.nlm.nih.gov/pubmed/34266486 http://dx.doi.org/10.1186/s13287-021-02482-8 |
Ejemplares similares
-
Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure
por: Razeghian-Jahromi, Iman, et al.
Publicado: (2020) -
Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy
por: Razeghian-Jahromi, Iman, et al.
Publicado: (2021) -
Mesenchymal stem cells: amazing remedies for bone and cartilage defects
por: Kangari, Parisa, et al.
Publicado: (2020) -
Emergence of signs of neural cells after exposure of bone marrow-derived mesenchymal stem cells to fetal brain extract
por: Jahromi, Iman Razeghian, et al.
Publicado: (2017) -
Detection of Coronary Artery Disease by an Erectile Dysfunction Questionnaire
por: Sayadi, Mehrab, et al.
Publicado: (2021)